Jupiter Neurosciences (JUNS) Stock Insights
JUNS$2.46-0.04 -1.80%
$3.24M
Market Cap
—
P/E
—
Forward P/E
—
Score
JUNS price $2.46 -0.04 -1.80%
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system…
Insights · Dividends · Forecast · Financials · Learn
$3.24M
Market Cap
—
P/E
—
Forward P/E
—
Score